Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
Primary Purpose
Pelvic Organ Prolapse, Quality of Life
Status
Unknown status
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Vaginal Pessary
Sponsored by
About this trial
This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring Pelvic Organ Prolapse, Quality of Life, Symptoms, Pessary, Treatment
Eligibility Criteria
Inclusion Criteria:
- Symptomatic Pelvic Organ Prolapse
- Commitment to attend controls
- Current negative cervical cytology
- Informed consent signed
Exclusion Criteria:
- Urinary incontinence as the only Pessary Indication
- Vaginal bleeding of undetermined cause
- Unable to return to controls
Sites / Locations
- Unidad de Uroginecologia, Complejo Asistencial Dr. Sotero del RioRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Vaginal Pessary
Arm Description
Pessary users for at least 12 months
Outcomes
Primary Outcome Measures
Quality of Life changes in pessary users for symptomatic Pelvic Organs Prolapse
At baseline, 6 and 12 month the Chilean Version of the P-QoL survey will be applied to describe the QoL changes
Pelvic Floor Disorders symptoms changes in pessary users for symptomatic Pelvic Organs Prolapse
At baseline, 6 and 12 month the Chilean Version of the Pelvic Distress Inventory - 20 (PDFI-20) survey will be applied to describe the symptoms changes
Sexual response changes in pessary sexually active women users for symptomatic Pelvic Organs Prolapse
At baseline, 6 and 12 month the Chilean Version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) survey will be applied to describe the Sexually response changes
Subjective impression of improvement after pessary use for symptomatic Pelvic Organs Prolapse
At baseline, 6 and 12 month the Patient Global Impression of Improvement (PGI-I) survey will be applied to describe the subjective improvement
Successful usage of pessary
If an enrolled patients is still using the pessary as the treatment for the pelvic organ prolapse will be considered as "successful".
Risk factors for unsuccessful pessary used will be measure using baseline characteristics.
Secondary Outcome Measures
Full Information
NCT ID
NCT02113969
First Posted
April 9, 2014
Last Updated
November 17, 2014
Sponsor
Servicio de Salud Metropolitano Sur Oriente
Collaborators
Pontificia Universidad Catolica de Chile
1. Study Identification
Unique Protocol Identification Number
NCT02113969
Brief Title
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
Official Title
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
Study Type
Interventional
2. Study Status
Record Verification Date
November 2014
Overall Recruitment Status
Unknown status
Study Start Date
September 2013 (undefined)
Primary Completion Date
March 2015 (Anticipated)
Study Completion Date
March 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Servicio de Salud Metropolitano Sur Oriente
Collaborators
Pontificia Universidad Catolica de Chile
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Genital prolapse is a common condition (up 20%), affecting the quality of life. Treatment can be surgical or conservative using vaginal pessaries. These devices are introduced into the vagina aiming to reduces the prolapse.
Pessaries have shown effectiveness in improving symptoms and quality of life. There are no randomized studies comparing them with surgery. This study design would be difficult to perform, because the inclusion criteria for both treatments are different. There are no currently standard protocols for the use of pessaries. This makes harder to widespread the usage of this conservative treatment.
The aim of the investigators is to identify variables that influence the success of conservative management of genital prolapse at 1 year of follow up. Using these variables and an expert panel opinion the investigators will develop a standardized protocol for pessary management.
Chile has a primary gynecological care system based midwives. Therefore having algorithms for pessaries usage becomes relevant. This algorithm can be implemented with basic training. This would increase the respond capacity, by the health care system to this disease, considering the scarce access to surgery.
The investigators hypothesis is: It is possible to generate a standardized protocol of conservative management of symptomatic genital prolapse in patient's beneficiary of public health system in Santiago, Chile, using pessaries through a prospective cohort study based in the success of these devices with 1 year of follow up, measured with questionnaires of symptoms, quality of life and sexuality
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse, Quality of Life
Keywords
Pelvic Organ Prolapse, Quality of Life, Symptoms, Pessary, Treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
294 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Vaginal Pessary
Arm Type
Experimental
Arm Description
Pessary users for at least 12 months
Intervention Type
Device
Intervention Name(s)
Vaginal Pessary
Intervention Description
Pessary fitting session at recruitment, follow up at 1 week, then monthly to complete 1 year follow up. QoL, symptoms and sexual function Surveys will be conducted at recruitment, 6 and 12 month. The absence of bacterial vaginosis (through study of vaginal discharge and pH) will be checked prior to positioning pessary and then each control. At the end of follow up period the success related variables will be determine with a statistical model. This information will be analyzed by an expert panel aiming to identify relevant clinical variables not included. This panel will generate a Standardized Management Protocol for symptomatic pelvic organ prolapse using vaginal pessaries.
Primary Outcome Measure Information:
Title
Quality of Life changes in pessary users for symptomatic Pelvic Organs Prolapse
Description
At baseline, 6 and 12 month the Chilean Version of the P-QoL survey will be applied to describe the QoL changes
Time Frame
6 months and 12 months
Title
Pelvic Floor Disorders symptoms changes in pessary users for symptomatic Pelvic Organs Prolapse
Description
At baseline, 6 and 12 month the Chilean Version of the Pelvic Distress Inventory - 20 (PDFI-20) survey will be applied to describe the symptoms changes
Time Frame
6 months and 12 months
Title
Sexual response changes in pessary sexually active women users for symptomatic Pelvic Organs Prolapse
Description
At baseline, 6 and 12 month the Chilean Version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) survey will be applied to describe the Sexually response changes
Time Frame
6 months and 12 months
Title
Subjective impression of improvement after pessary use for symptomatic Pelvic Organs Prolapse
Description
At baseline, 6 and 12 month the Patient Global Impression of Improvement (PGI-I) survey will be applied to describe the subjective improvement
Time Frame
6 months and 12 months
Title
Successful usage of pessary
Description
If an enrolled patients is still using the pessary as the treatment for the pelvic organ prolapse will be considered as "successful".
Risk factors for unsuccessful pessary used will be measure using baseline characteristics.
Time Frame
12 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Symptomatic Pelvic Organ Prolapse
Commitment to attend controls
Current negative cervical cytology
Informed consent signed
Exclusion Criteria:
Urinary incontinence as the only Pessary Indication
Vaginal bleeding of undetermined cause
Unable to return to controls
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Javier Pizarro, MD
Phone
216 583-6220
Email
jpizarro@med.puc.cl
First Name & Middle Initial & Last Name or Official Title & Degree
Bernardita Blumel, MD
Phone
56 9 82328165
Email
bernarditablumel@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Javier Pizarro, MD
Organizational Affiliation
Complejo Asistencial Dr. Sotero del Rio
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Bernardita Blumel, MD
Organizational Affiliation
Complejo Asistencial Dr. Sotero del Rio
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Silvana Gonzalez, Midwife
Organizational Affiliation
Complejo Asistencial Dr. Sotero del Rio
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Alejandro Pattillo, MD
Organizational Affiliation
H. Dr. Sotero del Rio; Pontificia Universidad Católica de Chile
Official's Role
Study Director
Facility Information:
Facility Name
Unidad de Uroginecologia, Complejo Asistencial Dr. Sotero del Rio
City
Santiago
State/Province
Region Metropolitana
ZIP/Postal Code
8207257
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Javier Pizarro, MD
Phone
216-583-6220
Email
jpizarro@med.puc.cl
First Name & Middle Initial & Last Name & Degree
Bernardita Blumel, MD
Phone
56 9 8232 8165
Email
bernarditablumel@gmail.com
First Name & Middle Initial & Last Name & Degree
Javier Pizarro, MD
First Name & Middle Initial & Last Name & Degree
Bernardita Blumel, MD
First Name & Middle Initial & Last Name & Degree
Silvana Gonzalez, Midwife
First Name & Middle Initial & Last Name & Degree
Rodrigo Cuevas, MD
First Name & Middle Initial & Last Name & Degree
Alejandro Pattillo, MD
First Name & Middle Initial & Last Name & Degree
Marco Arellano, MD
First Name & Middle Initial & Last Name & Degree
Rodrigo Pineda, MD
First Name & Middle Initial & Last Name & Degree
Victor Miranda, Md, MsC
First Name & Middle Initial & Last Name & Degree
Oslando Padilla, MsC
First Name & Middle Initial & Last Name & Degree
Howard B Goldman, MD
12. IPD Sharing Statement
Learn more about this trial
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
We'll reach out to this number within 24 hrs